These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38551039)

  • 21. Erythropoietin: A potential drug in the management of diabetic neuropathy.
    Suarez-Mendez S; Tovilla-Zárate CA; Juárez-Rojop IE; Bermúdez-Ocaña DY
    Biomed Pharmacother; 2018 Sep; 105():956-961. PubMed ID: 30021390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy Collateral Glucose-Utilizing Pathways in Diabetic Polyneuropathy.
    Mizukami H; Osonoi S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic Neuropathy: Pathophysiology Review.
    Strand N; Anderson MA; Attanti S; Gill B; Wie C; Dawodu A; Pagan-Rosado R; Harbell MW; Maloney JA
    Curr Pain Headache Rep; 2024 Jun; 28(6):481-487. PubMed ID: 38558164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catechin attenuates diabetic autonomic neuropathy in streptozotocin induced diabetic rats.
    Addepalli V; Suryavanshi SV
    Biomed Pharmacother; 2018 Dec; 108():1517-1523. PubMed ID: 30372853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of miR-25 aggravates diabetic peripheral neuropathy.
    Zhang Y; Song C; Liu J; Bi Y; Li H
    Neuroreport; 2018 Aug; 29(11):945-953. PubMed ID: 29877948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic neuropathy: an intensive review.
    Duby JJ; Campbell RK; Setter SM; White JR; Rasmussen KA
    Am J Health Syst Pharm; 2004 Jan; 61(2):160-73; quiz 175-6. PubMed ID: 14750401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
    Kuhad A; Chopra K
    Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic neuropathy: Pathogenesis and evolving principles of management.
    Zaino B; Goel R; Devaragudi S; Prakash A; Vaghamashi Y; Sethi Y; Patel N; Kaka N
    Dis Mon; 2023 Sep; 69(9):101582. PubMed ID: 37164794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.
    Shen H; Zhao J; Liu Y; Sun G
    J Diabetes Res; 2018; 2018():3458615. PubMed ID: 30116739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway.
    Chen J; Liu W; Yi H; Hu X; Peng L; Yang F
    Cell Physiol Biochem; 2018; 48(3):1164-1176. PubMed ID: 30045011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment.
    Lin Q; Li K; Chen Y; Xie J; Wu C; Cui C; Deng B
    Mol Neurobiol; 2023 Aug; 60(8):4574-4594. PubMed ID: 37115404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy.
    Sood A; Kumar B; Singh SK; Prashar P; Gautam A; Gulati M; Pandey NK; Melkani I; Awasthi A; Saraf SA; Vidari G; Ozdemir M; Hussain FHS; Anwar ET; Ameen MSM; Gupta S; Porwal O
    Curr Pharm Des; 2020; 26(42):5468-5487. PubMed ID: 32851955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
    Hilz MJ; Marthol H; Neundörfer B
    Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment.
    Zhu J; Hu Z; Luo Y; Liu Y; Luo W; Du X; Luo Z; Hu J; Peng S
    Front Endocrinol (Lausanne); 2023; 14():1265372. PubMed ID: 38264279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.
    Figueroa-Romero C; Sadidi M; Feldman EL
    Rev Endocr Metab Disord; 2008 Dec; 9(4):301-14. PubMed ID: 18709457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding Diabetic Neuropathy: Focus on Oxidative Stress.
    Pang L; Lian X; Liu H; Zhang Y; Li Q; Cai Y; Ma H; Yu X
    Oxid Med Cell Longev; 2020; 2020():9524635. PubMed ID: 32832011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy.
    Bönhof GJ; Herder C; Strom A; Papanas N; Roden M; Ziegler D
    Endocr Rev; 2019 Feb; 40(1):153-192. PubMed ID: 30256929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biology of diabetic neuropathy.
    Vincent AM; Calabek B; Roberts L; Feldman EL
    Handb Clin Neurol; 2013; 115():591-606. PubMed ID: 23931804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.
    Miranda-Massari JR; Gonzalez MJ; Jimenez FJ; Allende-Vigo MZ; Duconge J
    Curr Clin Pharmacol; 2011 Nov; 6(4):260-73. PubMed ID: 22082324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
    Obrosova IG; Julius UA
    Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.